In the agreement, SensID gives TATAA full access to its growing product portfolio for molecular diagnostics and TATAA will represent SensID in Sweden, Denmark, Norway, Finland, Czech and Slovak Republics.

“With its strong focus on reference materials for molecular diagnostics, SensID is a perfect solution provider for our services. The SenseID products are also most attractive to our quality conscious customers,” says Professor Mikael Kubista, CEO and founder of TATAA Biocenter.

“We are very proud that TATAA is now a partner supporting fast market entry of our novel MDx reference materials,” says Björn Nowack, CEO and co-founder of SensID.